Endothelial senescence contributes to vascular dysfunction and the development of atherosclerosis. Mitochondrial damage, oxidative stress and persistent inflammation are closely associated with this process. Mitophagy is an important component of mitochondrial quality control that removes damaged mitochondria and helps maintain endothelial homeostasis. When mitochondrial clearance is impaired, damaged mitochondria can accumulate and promote changes associated with endothelial senescence. In this Review, we discuss the molecular mechanisms of mitophagy, including the PINK1/Parkin pathway and receptor-mediated pathways involving BNIP3, NIX and FUNDC1. We examine how these pathways influence endothelial senescence and function, and assess the evidence for their roles in atherosclerosis. Particular attention is given to the distinction between findings in atherosclerosis models and those in other vascular diseases, as well as to whether the reported effects are mediated by mitophagy. Finally, we discuss the potential of targeting mitophagy to preserve endothelial function and identify questions that remain to be addressed.




